相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Optimal age and outcome measures for Alzheimer's disease prevention trials in people with Down syndrome
Rosalyn Hithersay et al.
ALZHEIMERS & DEMENTIA (2021)
Nerve growth factor (NGF) pathway biomarkers in Down syndrome prior to and after the onset of clinical Alzheimer's disease: A paired CSF and plasma study
Rowan Pentz et al.
ALZHEIMERS & DEMENTIA (2021)
Plasma Total-Tau and Neurofilament Light Chain as Diagnostic Biomarkers of Alzheimer's Disease Dementia and Mild Cognitive Impairment in Adults with Down Syndrome
Melissa E. Petersen et al.
JOURNAL OF ALZHEIMERS DISEASE (2021)
Alzheimer's disease
Philip Scheltens et al.
LANCET (2021)
Systematic review of coexistent epileptic seizures and Alzheimer's disease: Incidence and prevalence
Ying Xu et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2021)
Establishing diagnostic thresholds for Alzheimer's disease in adults with Down syndrome: the Cambridge Examination for Mental Disorders of Older People with Down's Syndrome and Others with Intellectual Disabilities (CAMDEX-DS)
Jessica A. Beresford-Webb et al.
BJPSYCH OPEN (2021)
Metabolite Signature of Alzheimer's Disease in Adults with Down Syndrome
Victor Montal et al.
ANNALS OF NEUROLOGY (2021)
Use of plasma biomarkers for AT(N) classification of neurodegenerative dementias
Daniel Alcolea et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2021)
Comparison of CSF biomarkers in Down syndrome and autosomal dominant Alzheimer's disease: a cross-sectional study
Anne M. Fagan et al.
LANCET NEUROLOGY (2021)
Diagnostic and prognostic performance and longitudinal changes in plasma neurofilament light chain concentrations in adults with Down syndrome: a cohort study
Maria Carmona-Iragui et al.
LANCET NEUROLOGY (2021)
Phosphorylated tau181 in plasma as a potential biomarker for Alzheimer's disease in adults with Down syndrome
Alberto Lleo et al.
NATURE COMMUNICATIONS (2021)
Association of Apolipoprotein E ε4 Allele With Clinical and Multimodal Biomarker Changes of Alzheimer Disease in Adults With Down Syndrome
Alexandre Bejanin et al.
JAMA NEUROLOGY (2021)
Epilepsy in Down Syndrome: A Highly Prevalent Comorbidity
Miren Altuna et al.
JOURNAL OF CLINICAL MEDICINE (2021)
Ultrastructural and dynamic studies of the endosomal compartment in Down syndrome
Alexandra Botte et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2020)
Prognostic Accuracy of Fetal MRI in Predicting Postnatal Neurodevelopmental Outcome
M. Wilson et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2020)
Alzheimer-Related Cerebrovascular Disease in Down Syndrome
Patrick J. Lao et al.
ANNALS OF NEUROLOGY (2020)
Plasma neurofilament light chain in the presenilin 1 E280A autosomal dominant Alzheimer's disease kindred: a cross-sectional and longitudinal cohort study
Yakeel T. Quiroz et al.
LANCET NEUROLOGY (2020)
Cause of death in adults with Down syndrome in the United StatesCause of death in adults with Down syndrome in the United States
Scott D. Landes et al.
DISABILITY AND HEALTH JOURNAL (2020)
Cerebrospinal fluid profile of NPTX2 supports role of Alzheimer's disease-related inhibitory circuit dysfunction in adults with Down syndrome
Olivia Belbin et al.
MOLECULAR NEURODEGENERATION (2020)
Association of sleep with cognition and beta amyloid accumulation in adults with Down syndrome
Karly A. Cody et al.
NEUROBIOLOGY OF AGING (2020)
Evolution of neuroinflammation across the lifespan of individuals with Down syndrome
Lisi Flores-Aguilar et al.
BRAIN (2020)
Comparison of longitudinal Aβ in nondemented elderly and Down syndrome
Dana L. Tudorascu et al.
NEUROBIOLOGY OF AGING (2019)
Dementia in Down syndrome: unique insights for Alzheimer disease research
Ira T. Lott et al.
NATURE REVIEWS NEUROLOGY (2019)
Blood-based molecular biomarkers for Alzheimer's disease
Henrik Zetterberg et al.
MOLECULAR BRAIN (2019)
Down syndrome, Alzheimer disease, and cerebral amyloid angiopathy: The complex triangle of brain amyloidosis
Maria Carmona-Iragui et al.
DEVELOPMENTAL NEUROBIOLOGY (2019)
Cognitive markers of preclinical and prodromal Alzheimer's disease in Down syndrome
Carla M. Startin et al.
ALZHEIMERS & DEMENTIA (2019)
Association of Dementia With Mortality Among Adults With Down Syndrome Older Than 35 Years
Rosalyn Hithersay et al.
JAMA NEUROLOGY (2019)
Frontal cortex and striatal cellular and molecular pathobiology in individuals with Down syndrome with and without dementia
Sylvia E. Perez et al.
ACTA NEUROPATHOLOGICA (2019)
Predictors of Age of Diagnosis and Survival of Alzheimer's Disease in Down Syndrome
Amanda Sinai et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
Patterns and severity of vascular amyloid in Alzheimer's disease associated with duplications and missense mutations in APP gene, Down syndrome and sporadic Alzheimer's disease
David M. A. Mann et al.
ACTA NEUROPATHOLOGICA (2018)
Early striatal amyloid deposition distinguishes Down syndrome and autosomal dominant Alzheimer's disease from late-onset amyloid deposition
Ann D. Cohen et al.
ALZHEIMERS & DEMENTIA (2018)
NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
Clifford R. Jack et al.
ALZHEIMERS & DEMENTIA (2018)
Trisomy of human chromosome 21 enhances amyloid-beta deposition independently of an extra copy of APP
Frances K. Wiseman et al.
BRAIN (2018)
The Behavioral and Psychological Symptoms of Dementia in Down Syndrome (BPSD-DS) Scale: Comprehensive Assessment of Psychopathology in Down Syndrome
Alain D. Dekker et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
Tau Positron Emission Tomography in Autosomal Dominant Alzheimer Disease Small Windows, Big Picture
Eric McDade et al.
JAMA NEUROLOGY (2018)
Neuroimaging and other modalities to assess Alzheimer's disease in Down syndrome
Natalie Neale et al.
NEUROIMAGE-CLINICAL (2018)
Aging related cognitive changes associated with Alzheimer's disease in Down syndrome
Nicholas C. Firth et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2018)
Plasma and CSF biomarkers for the diagnosis of Alzheimer's disease in adults with Down syndrome: a cross-sectional study
Juan Fortea et al.
LANCET NEUROLOGY (2018)
]Prevalence of Sleep Disorders in Adults With Down Syndrome: A Comparative Study of Self-Reported, Actigraphic, and Polysomnographic Findings
Sandra Gimenez et al.
JOURNAL OF CLINICAL SLEEP MEDICINE (2018)
The clinical and neurobehavioral course of Down syndrome and dementia with or without new-onset epilepsy
Taha Gholipour et al.
EPILEPSY & BEHAVIOR (2017)
PET Imaging of Tau Pathology and Relationship to Amyloid, Longitudinal MRI, and Cognitive Change in Down Syndrome: Results from the Down Syndrome Biomarker Initiative (DSBI)
Michael S. Rafii et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Down Syndrome, Partial Trisomy 21, and Absence of Alzheimer's Disease: The Role of APP
Eric Doran et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
The Down syndrome brain in the presence and absence of fibrillar β-amyloidosis
Tiina Annus et al.
NEUROBIOLOGY OF AGING (2017)
Cognitive decline and brain amyloid-β accumulation across 3 years in adults with Down syndrome
Sigan L. Hartley et al.
NEUROBIOLOGY OF AGING (2017)
The Early Presentation of Dementia in People with Down Syndrome: a Systematic Review of Longitudinal Studies
Bianca Alexandra Lautarescu et al.
NEUROPSYCHOLOGY REVIEW (2017)
Trisomy 21 causes changes in the circulating proteome indicative of chronic autoinflammation
Kelly D. Sullivan et al.
SCIENTIFIC REPORTS (2017)
Cerebrovascular pathology in Down syndrome and Alzheimer disease
Elizabeth Head et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2017)
Cerebral amyloid angiopathy in Down syndrome and sporadic and autosomal-dominant Alzheimer's disease
Maria Carmona-Iragui et al.
ALZHEIMERS & DEMENTIA (2017)
Estimation of live birth and population prevalence of Down syndrome in nine US states
Gert de Graaf et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2017)
A prospective 20-year longitudinal follow-up of dementia in persons with Down syndrome
M. McCarron et al.
JOURNAL OF INTELLECTUAL DISABILITY RESEARCH (2017)
The Arizona Cognitive Test Battery for Down Syndrome: Test-Retest Reliability and Practice Effects
Jamie O. Edgin et al.
AJIDD-AMERICAN JOURNAL ON INTELLECTUAL AND DEVELOPMENTAL DISABILITIES (2017)
Outcome Measures for Clinical Trials in Down Syndrome
Anna J. Esbensen et al.
AJIDD-AMERICAN JOURNAL ON INTELLECTUAL AND DEVELOPMENTAL DISABILITIES (2017)
Neuronal exosomes reveal Alzheimer's disease biomarkers in Down syndrome
Eric D. Hamlett et al.
ALZHEIMERS & DEMENTIA (2017)
White Matter Hyperintensities Are a Core Feature of Alzheimer's Disease: Evidence from the Dominantly Inherited Alzheimer Network
Seonjoo Lee et al.
ANNALS OF NEUROLOGY (2016)
CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis
Bob Olsson et al.
LANCET NEUROLOGY (2016)
Assessing Specific Cognitive Deficits Associated with Dementia in Older Adults with Down Syndrome: Use and Validity of the Arizona Cognitive Test Battery (ACTB)
Amanda Sinai et al.
PLOS ONE (2016)
Epilepsy in children with Down syndrome: not so benign as generally accepted
Marisse Meeus et al.
ACTA NEUROLOGICA BELGICA (2015)
Down syndrome individuals with Alzheimer's disease have a distinct neuroinflammatory phenotype compared to sporadic Alzheimer's disease
Donna M. Wilcock et al.
NEUROBIOLOGY OF AGING (2015)
Associations Between Biomarkers and Age in the Presenilin 1 E280A Autosomal Dominant Alzheimer Disease Kindred A Cross-sectional Study
Adam S. Fleisher et al.
JAMA NEUROLOGY (2015)
Cerebrospinal fluid biomarkers in trials for Alzheimer and Parkinson diseases
Alberto Lleo et al.
NATURE REVIEWS NEUROLOGY (2015)
Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria
Bruno Dubois et al.
LANCET NEUROLOGY (2014)
Changes in mortality and causes of death in the Swedish Down syndrome population
Annika Englund et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2013)
Dominantly Inherited Alzheimer Network: facilitating research and clinical trials
Krista L. Moulder et al.
ALZHEIMERS RESEARCH & THERAPY (2013)
Association between frontal cortex oxidative damage and beta-amyloid as a function of age in Down syndrome
Giovanna Cenini et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2012)
Memantine for dementia in adults older than 40 years with Down's syndrome (MEADOWS): a randomised, double-blind, placebo-controlled trial
Marisa Hanney et al.
LANCET (2012)
Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
Randall J. Bateman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
TDP-43 pathological changes in early onset familial and sporadic Alzheimer's disease, late onset Alzheimer's disease and Down's Syndrome: association with age, hippocampal sclerosis and clinical phenotype
Yvonne S. Davidson et al.
ACTA NEUROPATHOLOGICA (2011)
Clinical and EEG Features of Seizures in Adults With Down Syndrome
Stela Lefter et al.
JOURNAL OF CLINICAL NEUROPHYSIOLOGY (2011)
Pre-dementia clinical stages in presenilin 1 E280A familial early-onset Alzheimer's disease: a retrospective cohort study
Natalia Acosta-Baena et al.
LANCET NEUROLOGY (2011)
Cognitive deficits and associated neurological complications in individuals with Down's syndrome
Ira T. Lott et al.
LANCET NEUROLOGY (2010)
Variations in the neuropathology of familial Alzheimer's disease
Claire Shepherd et al.
ACTA NEUROPATHOLOGICA (2009)
High Striatal Amyloid β-Peptide Deposition Across Different Autosomal Alzheimer Disease Mutation Types
Victor L. Villemagne et al.
ARCHIVES OF NEUROLOGY (2009)
Transactive Response DNA-Binding Protein 43 Burden in Familial Alzheimer Disease and Down Syndrome
Carol F. Lippa et al.
ARCHIVES OF NEUROLOGY (2009)
Oxidative stress and cognitive ability in adults with Down syndrome
Andre Strydom et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2009)
Significant effect of APOE Epsilon 4 Genotype on the risk of dementia in Alzheimer's disease and mortality in persons with Down Syndrome
V. P. Prasher et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2008)
Elevated plasma β-amyloid peptide Aβ42 levels, incident dementia, and mortality in Down syndrome
Nicole Schupf et al.
ARCHIVES OF NEUROLOGY (2007)
Increase in beta-amyloid levels in cerebrospinal fluid of children with down syndrome
Hillevi Englund et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2007)
Pattern of increased cerebral FDG uptake in Down syndrome patients
Z Lengyel et al.
PEDIATRIC NEUROLOGY (2006)
Temporal cortex hypermetabolism in Down syndrome prior to the onset of dementia
RJ Haier et al.
NEUROLOGY (2003)
The accuracy of medicare claims data in identifying Alzheimer's disease
DH Taylor et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2002)
Altered metabolism of the amyloid β precursor protein is associated with mitochondrial dysfunction in Down's syndrome
J Busciglio et al.
NEURON (2002)
Endocytic pathway abnormalities precede amyloid β deposition in sporadic Alzheimer's disease and Down syndrome -: Differential effects of APOE genotype and presenilin mutations
AM Cataldo et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
分享论文
